Seaport Therapeutics, Inc. (SPTX)
NASDAQ: SPTX · Real-Time Price · USD
16.05
+0.55 (3.55%)
At close: May 8, 2026, 4:00 PM EDT
16.49
+0.44 (2.74%)
After-hours: May 8, 2026, 6:18 PM EDT
Seaport Therapeutics Market Cap
Seaport Therapeutics has a market cap or net worth of $851.1 million as of May 8, 2026.
Market Cap
851.10M
Enterprise Value
640.19M
1-Year Change
n/a
Ranking
Category
Stock Price
16.05
Market Cap Chart
Since the IPO on May 1, 2026, Seaport Therapeutics's market cap has decreased from $912.02M to $851.10M, a decrease of -6.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 851.10M | 3.55% |
| May 7, 2026 | 821.93M | -3.13% |
| May 6, 2026 | 848.45M | - |
| May 5, 2026 | 848.45M | -5.88% |
| May 4, 2026 | 901.47M | -1.16% |
| May 1, 2026 | 912.02M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Geron | 891.71M |
| Design Therapeutics | 888.14M |
| Theravance Biopharma | 876.27M |
| ARS Pharmaceuticals | 867.89M |
| CytomX Therapeutics | 866.42M |
| Janux Therapeutics | 864.13M |
| Arbutus Biopharma | 854.72M |
| Alto Neuroscience | 850.38M |